Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.
- NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_assertion description "[A combined ELISA for both LY6K and CEA classified 64.7% of lung adenocarcinoma patients as positive, and the use of both LY6K and CYFRA 21-1 increased sensitivity in the detection of lung squamous cell carcinomas and ESCCs up to 70.4% and 52.5%, respectively, whereas the false positive rate was 6.8% to 9.5%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.
- NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_assertion evidence source_evidence_literature NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.
- NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_assertion SIO_000772 18089789 NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.
- NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_assertion wasDerivedFrom befree-2016 NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.
- NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_assertion wasGeneratedBy ECO_0000203 NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.
- befree-2016 importedOn "2016-02-19" NP645932.RAPgM2KKnTKyiSuur1mT8eWpu5F_ijXEZdv0BPtsv__uU130_provenance.